LL 37

General Information


DRACP ID  DRACP00494

Peptide Name   LL 37

Sequence  LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES

Sequence Length  37

UniProt ID  Q1KLX1  P49913 

PubChem CID  Not available

Origin  Also known human cathelicidin

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MCF-7 Invasive breast carcinoma of no special type Carcinoma LC50=21 at 100 µM MTS assay 72 h 1
LNCaP Prostate carcinoma Carcinoma LC50=27 at 100 µM MTS assay 72 h 1
OVCAR-3 High grade ovarian serous adenocarcinoma Carcinoma LC50=24 at 100 µM MTS assay 72 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Primary dermal fibroblast: LC50=26 at 100 µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial



Structure Information


PDB ID  2K6O 

Predicted Structure  DRACP00494

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C205H340N60O53

Absent amino acids  ACHMWY

Common amino acids  K

Mass  513561

Pl  11.35

Basic residues  11

Acidic residues  5

Hydrophobic residues  13

Net charge  6

Boman Index  -11100

Hydrophobicity  -72.43

Aliphatic Index  89.46

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24587350

Title  Learning from host-defense peptides: cationic, amphipathic peptoids with potent anticancer activity

Doi 10.1371/journal.pone.0090397

Year  2014

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




CancerPPD ID  5002

CancerPPD ID  5004

CancerPPD ID  5006

DRACP is developed by Dr.Zheng's team.